Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hasan Ali

Showing results (641-650 of 696) with videos related to

Pageof 70
Sort By:
Antibiotics (Basel, Switzerland)|April 27, 2026
Mobile Genetic Elements as Central Drivers of Antimicrobial Resistance: Molecular Mechanisms, Evolutionary Ecology, One Health Implications and Control StrategiesHemayet Hossain, Md Hasan Ali, Tanvir Ahmad, et al.
European Journal of Heart Failure|October 12, 2023
Outcomes at one year in women with peripartum cardiomyopathy: Findings from the ESC EORP PPCM RegistryAlice M Jackson, Johann Bauersachs, Mark C Petrie, et al.
Journal of the American Academy of Dermatology|August 27, 2019
BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitorsOmar Hasan Ali, David Bomze, Sandra S Ring, et al.
Environmental Geochemistry and Health|September 18, 2025
Polyaromatic hydrocarbons and trace metals in road-deposited soil, source apportionment, and risk analysis: evidence from the largest port city of BangladeshMd Samrat Mohay Menul Islam, Md Nure Alam Siddik, Md Ashraful Islam, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|July 27, 2021
Potential for optimizing management of obesity in the secondary prevention of coronary heart diseaseDirk De Bacquer, Catriona S Jennings, Erkin Mirrakhimov, et al.
European Heart Journal|September 2, 2024
Bromocriptine treatment and outcomes in peripartum cardiomyopathy: the EORP PPCM registryPeter van der Meer, Bart Johan van Essen, Charle Viljoen, et al.
ESC Heart Failure|February 4, 2022
Egyptian expert opinion for the use of sodium-glucose cotransporter-2 inhibitors in patients with heart failure with reduced ejection fractionMagdy Abdelhamid, Hossam Kandil, Mahmoud Hassanin, et al.
JACC. Heart Failure|October 7, 2023
Proteomic Profiling in Patients With Peripartum Cardiomyopathy: A Biomarker Study of the ESC EORP PPCM RegistryVitaris Kodogo, Charle Viljoen, Julian Hoevelmann, et al.
Journal of Electrocardiology|August 31, 2024
Can the efficacy of a medical treatment be predicted based on the type of idiopathic premature ventricular contraction?Adem Atici, Irfan Sahin, Ömer Doğan, et al.
ESC Heart Failure|June 6, 2026
Global Trend and Predictors of Non-Labeled Sacubitril-Valsartan Dosing: Results from IKNOW-HF SurveyIsraa Fadhil Yaseen, Hasan Ali Farhan, Justin Paul Gnanaraj, et al.
Pageof 70

Showing results (641-650 of 696) with videos related to

Sort By:
Pageof 70
Antibiotics (Basel, Switzerland)|April 27, 2026
Mobile Genetic Elements as Central Drivers of Antimicrobial Resistance: Molecular Mechanisms, Evolutionary Ecology, One Health Implications and Control StrategiesHemayet Hossain, Md Hasan Ali, Tanvir Ahmad, et al.
European Journal of Heart Failure|October 12, 2023
Outcomes at one year in women with peripartum cardiomyopathy: Findings from the ESC EORP PPCM RegistryAlice M Jackson, Johann Bauersachs, Mark C Petrie, et al.
Journal of the American Academy of Dermatology|August 27, 2019
BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitorsOmar Hasan Ali, David Bomze, Sandra S Ring, et al.
Environmental Geochemistry and Health|September 18, 2025
Polyaromatic hydrocarbons and trace metals in road-deposited soil, source apportionment, and risk analysis: evidence from the largest port city of BangladeshMd Samrat Mohay Menul Islam, Md Nure Alam Siddik, Md Ashraful Islam, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|July 27, 2021
Potential for optimizing management of obesity in the secondary prevention of coronary heart diseaseDirk De Bacquer, Catriona S Jennings, Erkin Mirrakhimov, et al.
European Heart Journal|September 2, 2024
Bromocriptine treatment and outcomes in peripartum cardiomyopathy: the EORP PPCM registryPeter van der Meer, Bart Johan van Essen, Charle Viljoen, et al.
ESC Heart Failure|February 4, 2022
Egyptian expert opinion for the use of sodium-glucose cotransporter-2 inhibitors in patients with heart failure with reduced ejection fractionMagdy Abdelhamid, Hossam Kandil, Mahmoud Hassanin, et al.
JACC. Heart Failure|October 7, 2023
Proteomic Profiling in Patients With Peripartum Cardiomyopathy: A Biomarker Study of the ESC EORP PPCM RegistryVitaris Kodogo, Charle Viljoen, Julian Hoevelmann, et al.
Journal of Electrocardiology|August 31, 2024
Can the efficacy of a medical treatment be predicted based on the type of idiopathic premature ventricular contraction?Adem Atici, Irfan Sahin, Ömer Doğan, et al.
ESC Heart Failure|June 6, 2026
Global Trend and Predictors of Non-Labeled Sacubitril-Valsartan Dosing: Results from IKNOW-HF SurveyIsraa Fadhil Yaseen, Hasan Ali Farhan, Justin Paul Gnanaraj, et al.
Pageof 70